Vertaling van "service public avec des contraintes " (Nederlands → Frans) :

« Je trouve très injuste qu’on nous demande, qu’on nous oblige quelque part à assurer un service public avec des contraintes qui deviennent de plus en plus énormes en termes d’horaire de travail, de travail de nuit, de travail de week-end etc, sans que nous ayons des protections quelque part comme n’importe quel travailleur » [Docteur FK, femme, 33 ans, Namur - rural]
« Je trouve très injuste qu’on nous demande, qu’on nous oblige quelque part à assurer un service public avec des contraintes qui deviennent de plus en plus énormes en termes d’horaire de travail, de travail de nuit, de travail de week-end etc, sans que nous ayons des protections quelque part comme n’importe quel travailleur » [Docteur FK, femme, 33 ans, Namur]

BAPCOC (with FPS Public Health) Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Interdepartmental network on “information society services” (with FPS Economy) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI) Working group on blood of the Belgian Federal Supreme Health Council Working group on cells, tissues and organs of the Belgian Federal Supreme Health Council
BAPCOC (with FPS Public Health) Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Interdepartmental network on “information society services” (with FPS Economy) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI) Working group on blood of the Belgian Federal Supreme Health Council Working group on cells, tissues and organs of the Belgian Federal Supreme Health Council

BAPCOC (with FPS Public Health) Board for biosafety (with WIV - ISP and the Biosafety and Biotechnology Service) Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Professional Ethics Committee (with FPS Public Health - DG Animals - Plants - Foodstuffs) Strategic unit/RIZIV - INAMI
BAPCOC (with FPS Public Health) Board for biosafety (with WIV - ISP and the Biosafety and Biotechnology Service) Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Professional Ethics Committee (with FPS Public Health - DG Animals - Plants - Foodstuffs) Strategic unit/RIZIV - INAMI

At present there are five agents who belong to the internal FAMHP team and ten agents who are supplied by the ICT service of the FPS Public Health, with which an SLA has been concluded in order to bring to a successful conclusion the transfer of tools and IT skills from the former DG Medicinal Products to the FAMHP and ensure the continuity of service provision.
At present there are five agents who belong to the internal FAMHP team and ten agents who are supplied by the ICT service of the FPS Public Health, with which an SLA has been concluded in order to bring to a successful conclusion the transfer of tools and IT skills from the former DG Medicinal Products to the FAMHP and ensure the continuity of service provision.

The Federal Agency for Medicines and Health Products faced numerous challenges in 2007: constructing a dynamic and efficient public service thanks to the newly acquired autonomy and transparent and professional management; developing into an institution with a national and international reputation; and becoming a learning organisation, capable of meeting people’s expectations with regard to public health.
The Federal Agency for Medicines and Health Products faced numerous challenges in 2007: constructing a dynamic and efficient public service thanks to the newly acquired autonomy and transparent and professional management; developing into an institution with a national and international reputation; and becoming a learning organisation, capable of meeting people’s expectations with regard to public health.

The FAMHP was established by law on 20 July 2006 and as from 1 January 2007 completely took over the role and fields of competency of the Directorate-General for Medicinal Products (DG Medicinal Products) that was a part of the Federal Public Service (FPS) Public Health, Food Chain Security and Environment.
The FAMHP was established by law on 20 July 2006 and as from 1 January 2007 completely took over the role and fields of competency of the Directorate-General for Medicinal Products (DG Medicinal Products) that was a part of the Federal Public Service (FPS) Public Health, Food Chain Security and Environment.

The FAMHP has completely taken over the role and fields of competency of the Directorate-General for Medicinal Products (DG Medicinal Products) of the Federal Public Service (FPS) Public Health.
The FAMHP has completely taken over the role and fields of competency of the Directorate-General for Medicinal Products (DG Medicinal Products) of the Federal Public Service (FPS) Public Health.

Office de la Naissance et de l'Enfance odds ratio over-the-counter papanicolou plasma protein A polymerase chain reaction Public Health Laboratory Service pregnancy-induced hypertension proton pump inhibitor positive predictive value premature rupture of membranes routine antenatal anti-D prophylaxis Royal College of Obstetricians and Gynaecologists randomised controlled trial eferences rhesus D recombinant immunoblot assay Rijksinstituut voor Ziekte- en Invaliditeitsverzekering ribonucleic acid random plasma glucose rapid plasmin reagin test relative risk reagent strip testing standard deviation single entry two step symphysis-fundal height small for gestational age Scottish Intercollegiate Guidelines Network sexueel overdraagbare aandoening Society of Obstetricians and Gynaecologists of Canada symphysis pubis dysfunction Treponema pallidum haemagglutination assay thyroïd stimulating hormone nconjugated oestriol United Kingdom United States Centers for Disease Control and
oral glucose tolerance test Office de la Naissance et de l'Enfance odds ratio over-the-counter papanicolou plasma protein A polymerase chain reaction Public Health Laboratory Service pregnancy-induced hypertension proton pump inhibitor positive predictive value premature rupture of membranes routine antenatal anti-D prophylaxis Royal College of Obstetricians and Gynaecologists randomised controlled trial eferences rhesus D recombinant immunoblot assay Rijksinstituut voor Ziekte- en Invaliditeitsverzekering ribonucleic acid random plasma glucose rapid plasmin reagin test relative risk reagent strip testing standard deviation single entry two step symphysis-fundal height small for gestational age Scottish Intercollegiate Guidelines Network sexueel overdraagbare aandoening Society of Obstetricians and Gynaecologists of Canada symphysis pubis dysfunction Treponema pallidum haemagglutination assay thyroïd stimulating hormone nconjugated oestriol United Kingdom United States Centers for Disease Control and Prevention US Preventive Services Task Force ultrasound scan urinary tract infection Veneral Disease Research Laboratory (test for syphilis) vaginal examination Vlaamse Organisaties van Vroedvrouwen Vlaamse Vereniging voor Obstetrie en Gynaecologie Wereldgezondheidsorganisatie World Health Organization weighted mean difference Wetenschappelijke Vereniging van Vlaamse Huisartsen

However, the FAMHP also intends to be an effective public service and a fully fledged partner to the numerous players in the medicines and health product fields, all of whom supported the establishment of the Agency.
However, the FAMHP also intends to be an effective public service and a fully fledged partner to the numerous players in the medicines and health product fields, all of whom supported the establishment of the Agency.

Externe validatoren: Dirk De Wachter (Vlaams Agentschap Zorg en Gezondheid), Niel Hens (Universiteit Hasselt), Véronique Tellier (Service public de Wallonie - DG05 - DSE - OWS)
Validateurs externes : Dirk De Wachter (Vlaams Agentschap Zorg en Gezondheid), Niel Hens (Universiteit Hasselt), Véronique Tellier (Service public de Wallonie - DG05 - DSE - OWS)